1. Home
  2. DARE vs IZEA Comparison

DARE vs IZEA Comparison

Compare DARE & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • IZEA
  • Stock Information
  • Founded
  • DARE 2015
  • IZEA 2006
  • Country
  • DARE United States
  • IZEA United States
  • Employees
  • DARE N/A
  • IZEA N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • IZEA Advertising
  • Sector
  • DARE Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • DARE Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • DARE 26.3M
  • IZEA 29.1M
  • IPO Year
  • DARE N/A
  • IZEA N/A
  • Fundamental
  • Price
  • DARE $2.38
  • IZEA $2.52
  • Analyst Decision
  • DARE Strong Buy
  • IZEA
  • Analyst Count
  • DARE 3
  • IZEA 0
  • Target Price
  • DARE $12.50
  • IZEA N/A
  • AVG Volume (30 Days)
  • DARE 40.1K
  • IZEA 41.8K
  • Earning Date
  • DARE 08-11-2025
  • IZEA 08-13-2025
  • Dividend Yield
  • DARE N/A
  • IZEA N/A
  • EPS Growth
  • DARE N/A
  • IZEA N/A
  • EPS
  • DARE N/A
  • IZEA N/A
  • Revenue
  • DARE $25,909.00
  • IZEA $36,896,490.00
  • Revenue This Year
  • DARE $99,756.91
  • IZEA $22.24
  • Revenue Next Year
  • DARE $119.77
  • IZEA N/A
  • P/E Ratio
  • DARE N/A
  • IZEA N/A
  • Revenue Growth
  • DARE N/A
  • IZEA 7.17
  • 52 Week Low
  • DARE $2.35
  • IZEA $1.68
  • 52 Week High
  • DARE $4.60
  • IZEA $3.15
  • Technical
  • Relative Strength Index (RSI)
  • DARE 34.73
  • IZEA 42.63
  • Support Level
  • DARE $2.56
  • IZEA $2.54
  • Resistance Level
  • DARE $2.95
  • IZEA $2.76
  • Average True Range (ATR)
  • DARE 0.12
  • IZEA 0.14
  • MACD
  • DARE -0.05
  • IZEA -0.05
  • Stochastic Oscillator
  • DARE 8.45
  • IZEA 14.58

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: